To this purpose, low doses of systemic doxycycline (LD-SD) have been proven to inhibit both the expression and activation of stromal cells’ matrix metalloproteases 2 (MMP-2) and MMP-9, whose expression is particularly relevant to pterygium progression [22,23,24]. The gene discussed is MMP9; the disease is pterygium.